SULFALEAN POWDER

Land: Kanada

Sprache: Englisch

Quelle: Health Canada

Wirkstoff:

SULFATHIAZOLE SODIUM; SULFAMETHAZINE SODIUM

Verfügbar ab:

BIMEDA-MTC ANIMAL HEALTH INC

Dosierung:

189G; 378G

Darreichungsform:

POWDER

Zusammensetzung:

SULFATHIAZOLE SODIUM 189G; SULFAMETHAZINE SODIUM 378G

Verabreichungsweg:

ORAL

Einheiten im Paket:

590G/9.1/22.7KG

Verschreibungstyp:

Prescription

Therapiegruppe:

CATTLE; SWINE (PIGS); HORSES; SHEEP

Produktbesonderheiten:

Active ingredient group (AIG) number: 0206063001

Berechtigungsstatus:

APPROVED

Berechtigungsdatum:

2004-04-27

Gebrauchsinformation

Bimeda Version December 08 2017
_MAIN PANEL- ENGLISH: _
DIN 00142220
APPLE FLAVOUR
À LA SAVEUR DE POMME
_P R_
_SULFALEAN_
®_ _
_POWDER _
VETERINARY USE ONLY/USAGE VÉTÉRINAIRE SEULEMENT
ANTIBIOTIC/ANTIBIOTIQUE
NET 20 LBS (9.1 KG)
ACTIVE INGREDIENTS:
Each 590 g contains
Sodium
Sulfathiazole…………………………………………………….
189 g
Sodium
Sulfamethazine…………………………………………………
378 g
INDICATIONS:
CATTLE AND SHEEP: As an aid in the treatment of bacterial infections,
such as foot abscess, bacillary enteritis,
metritis, mastitis, septicemia accompanying acute mastitis and
shipping fever complex, and bacterial respiratory
infections, caused by bacteria susceptible to sulfathiazole and/or
sulfamethazine.
CALVES: As an aid in the treatment of the following conditions caused
by bacteria susceptible to sulfathiazole
and/or sulfamethazine: secondary infections in enteritis and bacterial
respiratory disease.
SWINE: As an aid in the treatment of the following conditions caused
by bacteria susceptible to sulfathiazole and/or
sulfamethazine: bacterial enteritis, acute mastitis, metritis, and
bacterial respiratory diseases.
HORSES: As an aid in the treatment of the following conditions caused
by bacteria susceptible to sulfathiazole
and/or sulfamethazine: strangles, acute bacterial infections,
bacterial enteritis, and many secondary bacterial
infections associated with respiratory virus infections.
DOSAGE AND ADMINISTRATION:
_To reduce the development of antimicrobial resistance and maintain
effectiveness, use this antibiotic prudently and _
_for the shortest duration required to achieve the desired clinical
outcome._
PREPARATION OF 12.5% SOLUTION: Dissolve 590 g (900 mL) in water to
make a total volume of 4.54 litres of solution
(graduated scoop enclosed).
DOSAGE: Administer as a drench, 1st day: 40 mL of 12.5% solution to
each 25 kg of body weight. 2nd day and
following days: one half of the above dosage.
WATER TROUGH MEDICATION: Dissolve 590 g in enough water to med